Open AccessCOVID-19 Tedavisine Yönelik Güncel Farmakolojik Yaklaşımlar
Author(s) -
Ezgi Eroğlu,
Hakan Balcı,
Veysel Baskin,
Zühal Aktuna
Publication year - 2021
Publication title -
yüksek i̇htisas üniversitesi sağlık bilimleri dergisi :
Language(s) - English
Resource type - Journals
ISSN - 2717-9257
DOI - 10.51261/yiu.2021.00018
Subject(s) - covid-19 , medicine , outbreak , adverse effect , coronavirus , randomized controlled trial , intensive care medicine , disease , virology , infectious disease (medical specialty)
The current outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in the wholesale market in Wuhan, China in the last months of 2019 and spread to almost all countries in the world. Although there is currently no specific treatment for COVID-19, certain agents are used worldwide, based on in vitro, in vivo studies, and randomized controlled trials. In this review, brief information about these drugs used for the treatment of COVID-19, the results of the conducted studies and the possible adverse effects of the drugs are summarized. We hope that this review will provide an impression of the most current therapeutic drugs used to prevent, control and treat COVID-19 patients until the approval of vaccines and specific drugs targeting SARS-CoV-2. Keywords: COVID-19, SARS CoV-2, pharmacotherapeutics